RENBIO – US Trademark 90309237 of RENBIO, INC.

Trademark image

RENBIO (U.S. Trademark Serial Number 90309237) is a United States trademark of RENBIO, INC.. The goods and services include: Chemical preparations for gene delivery pharmaceuticals for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals for the treatment of genetic or cell based conditions; Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical compositions for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Biological preparations for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical preparations for human use for the treatment and prevention of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; pharmaceutical preparations for human and veterinary use, namely, antibiotics, antifungals and anti-virals Biological products, namely, DNA circle, DNA primers, linear DNA and buffers for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals; Biological products, namely, antibodies, multi-specific antibodies, antibody fragments, proteins, chimeric proteins, drug conjugates and enzymes, for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals Medical apparatus for the administration of biopharmaceuticals and vaccines, namely, drug delivery devices and systems being pulse and waveform generators for the delivery of sub-dermal or intramuscular or intravenous drugs; medical devices, namely, pulse and waveform generators for electroporation mediated administration of drugs to humans and animals; delivery systems comprised of pulse and waveform generators for the delivery of sub-dermal or intramuscular or intravenous drugs for administration of biopharmaceuticals and vaccines for the preventive or treatment of disease in humans and animals; handheld medical systems and devices comprised of pulse and waveform generators using electroporation for the prevention or treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders in humans and animals; handheld clinical delivery systems and devices comprised of pulse and waveform generators for the application of electrical fields in tissue, in particular muscle and skin, in conjunction with the administration of biopharmaceuticals. The correspondent is Rachelle A. Dubow, Esq. of MORGAN, LEWIS & BOCKIUS LLP.

This trademark was filed on November 10, 2020 as United States Trademark Application Serial Number 90309237. This trademark application is still pending and does not yet have a registration number.

Trademark PTO Status History

July 01, 2022 – SOU EXTENSION 1 GRANTED

July 01, 2022 – SOU EXTENSION 1 FILED

July 01, 2022 – TEAS EXTENSION RECEIVED

May 19, 2022 – AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

January 04, 2022 – NOA E-MAILED – SOU REQUIRED FROM APPLICANT

November 09, 2021 – OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

November 09, 2021 – PUBLISHED FOR OPPOSITION

October 20, 2021 – NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

View full trademark status information at USPTO

Ownership History

RENBIO, INC.

RenBio, Inc.

RenBio, Inc.

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *